What is already known on this topic?
Introduction
being of childhood-onset and with survival up to adulthood with milder symptoms. The differential diagnosis is based on the onset age and severity of the disease (2) .
In this study, we describe a Chinese, male, newborn with hyperinsulinemia and hyperglycemia. Next generation sequencing (NGS) detected a compound heterozygous mutations of INSR, including one known mutation and one novel 2.43Kb deletion.
Case Report
The proband is a male infant and the first child of nonconsanguineous parents. During the fetal period, he was diagnosed with intrauterine growth retardation and oligohydramnios and was delivered by natural labor at 36 weeks of gestation with a low birth weight at 1.7 kg. At age 13 days, he presented with dry skin and heavy hair over his whole body. The plantar grasp, Moro and sucking reflexes were weak. Facial malformation, abnormality of mouth size, acanthosis nigricans and abdominal distention were not observed. Clinical tests showed hyperglycemia (14.7 mmol/L), hyperinsulinemia (>300 IU/mL) and fasting hypoglycemia. C-peptide was 4.05 ng/mL (1.10-4.40 ng/ mL). HbAlc (glycosylated hemoglobin) was normal (5.4%). Other abnormal laboratory test results are shown in Table 1 . Insulin auto-antibodies were negative. Routine blood tests, liver function tests and thyroid-stimulating hormone levels were normal. Echocardiography suggested a ventricular septal defect, an atrial septal defect and ultrasonography indicated swelling of both kidneys. Magnetic resonance imaging of the brain indicated an impaired myelination of internationalgenome.org/) have no record of this variant. This mutation was also the only record in our internal database, which contains sequencing data of ClearSeq of 4071 patients. Paired primers were designed by using Primer3 website and primer-BLAST (5'-GGGAGGAGAACCCTGGTGAG-3' and '-ATCCGAGGAGGCCAGGAG-3'). Sanger sequencing indicated that this mutation was inherited from the mother ( Figure  1A , 1B, 1C).
We used CANOES (CNVs with an Arbitrary Number of Exome Samples) for basic detection of CNVs from NGS data at genelevel and region-level (4 Figure 1D ). This deletion is not found in HGMD, DECIPHER or DGV. Additionally, it is absent from our internal database. The detected mutation was confirmed using realtime quantitative PCR. PCR-amplified DNA products were subjected to direct automated sequencing (ABI step one plus v.2.0). Both strands of each amplicon were sequenced using the primers 5'-CCTGACCTGGGGACGAAAA-3' and 5'-GTCTCCACCATTCGAGTCTGA-3'. Real-time quantitative PCR indicated the deletion was from the father ( Figure  1E ). This region covers part of exon 10 and all of exon 11. The deletion is estimated to cause a truncated protein.
We performed a three-dimensional (3D) structural modeling of 
Discussion
In Another gross deletion contains exon 18. This RMS patient, as a compound heterozygote, also carried a mutation (p.Val66Ala). Nephrocalcinosis was found to be one of the patient's dominant features (7) . For the patient we report, the missense mutation (c.3355C>T, p.R1119W) has been reported from a DS patient who had symptoms at birth and died at three months of age (3). Our patient had symptoms 13 days after birth. Some typical RMS features of this patient include abnormal glucose homeostasis, hyperinsulinemia, dry skin, thick hair, elevated testosterone and growth retardation. We diagnosed this patient as RMS. With a microdeletion, our patient presented a mild and atypical phenotype, which may be explained by the unclear genotype-phenotype correlation of mutations in INSR. Different missense mutations in the same codon relate to different phenotypes (8) . One DS patient, bearing a homozygous deletion in INSR resulting in inactivation of the INSR lived for 3.5 years (9). The coexistence of modifier genes and compensatory pathways may explain the phenotypic variability (10) .
The insulin receptor is a tetramer of two a monomers and two β monomers. It is widely expressed and plays a vital role as a mediator between the extracellular and intracellular insulin signaling pathway. The whole region of the a-subunit is extracellular. The a-subunit contains a Leu- (14) . 3D structural modeling indicates that with deficiencies in both a-subunit and β-subunit, IR may be unable to combine with insulin receptor substrates and recruit the downstream signaling molecules (15).
Our patient did not show some of the typical features of RMS including coarse face, gingival hyperplasia and acanthosis nigricans. These three symptoms can be absent in neonates and may develop in adolescence (16) . The insulin receptor is expressed in the heart and regulates cardiac cell activity though the PI3K-AKT pathway. Insulin receptor deficiency possibly leads to cardiac dysfunction, as observed in some patients (10, 17) and proven using animal models (18) . There is no evidence indicating any relationship between heart structural malformation and insulin receptors, so we consider that the ventricle septal defect is not a consequence of insulin receptor deficiency in this case. The long-term prognosis of RMS patients is poor (19) . Recombinant human insulin-like growth factor 1 and recombinant leptin are recommended for treatment of severe insulin resistance syndrome (19, 20) . However, the complications and safety of these drugs remain unknown (21) In summary, we show an RMS patient carrying one known pathogenic mutation and one novel deletion in INSR. Since the presenting clinical features of patients with insulin resistance syndrome can be atypical, when the diagnosis
